Metabotropic Glutamate Receptors – A highly selective inhibitor of Wnt pathway, as a potential topical treatment for cancer

Metabotropic Glutamate Receptors / April 11, 2023

Effective advocacy, built about powerful data, will be crucial to generate and mobilise the resources had a need to implement the street map also to ultimately ensure the sustainability from the approaches being proposed

Effective advocacy, built about powerful data, will be crucial to generate and mobilise the resources had a need to implement the street map…

Metabotropic Glutamate Receptors / January 24, 2023

Shocks (?) = no suitable shocks during follow-up; Shocks (+) = a number of suitable shocks during follow-up; Type D (?) = no Type D character; Type D (+) = Type D character

Shocks (?) = no suitable shocks during follow-up; Shocks (+) = a number of suitable shocks during follow-up; Type D (?) = no…

Metabotropic Glutamate Receptors / February 13, 2022

Additional laboratory and clinical studies are needed to further elucidate the interaction between tumor, tissue and system level factors

Additional laboratory and clinical studies are needed to further elucidate the interaction between tumor, tissue and system level factors. A potential limitation of…

Metabotropic Glutamate Receptors / January 28, 2022

FCS was then added to stop the enzymatic action, and tumor tissues were transferred to ice

FCS was then added to stop the enzymatic action, and tumor tissues were transferred to ice. T cell responses were observed against model-,…

Wnt inhibitors

Category: Metabotropic Glutamate Receptors

Effective advocacy, built about powerful data, will be crucial to generate and mobilise the resources had a need to implement the street map also to ultimately ensure the sustainability from the approaches being proposed

Shocks (?) = no suitable shocks during follow-up; Shocks (+) = a number of suitable shocks during follow-up; Type D (?) = no Type D character; Type D (+) = Type D character

Additional laboratory and clinical studies are needed to further elucidate the interaction between tumor, tissue and system level factors

FCS was then added to stop the enzymatic action, and tumor tissues were transferred to ice

﻿Effective advocacy, built about powerful data, will be crucial to generate and mobilise the resources had a need to implement the street map also to ultimately ensure the sustainability from the approaches being proposed

﻿Shocks (?) = no suitable shocks during follow-up; Shocks (+) = a number of suitable shocks during follow-up; Type D (?) = no Type D character; Type D (+) = Type D character

﻿Additional laboratory and clinical studies are needed to further elucidate the interaction between tumor, tissue and system level factors

﻿FCS was then added to stop the enzymatic action, and tumor tissues were transferred to ice

Effective advocacy, built about powerful data, will be crucial to generate and mobilise the resources had a need to implement the street map also to ultimately ensure the sustainability from the approaches being proposed

Shocks (?) = no suitable shocks during follow-up; Shocks (+) = a number of suitable shocks during follow-up; Type D (?) = no Type D character; Type D (+) = Type D character

Additional laboratory and clinical studies are needed to further elucidate the interaction between tumor, tissue and system level factors

FCS was then added to stop the enzymatic action, and tumor tissues were transferred to ice